Sickle Cell Disease Pipeline
Sickle Cell Disease Pipeline 2025 Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | Sanofi, Novartis AG, Bluebird Biotech, Pfizer Inc., Aruvant Sciences Inc., Glycomimetics, Global Blood Therapeutics Inc., Emmaus Medical Inc., Addmedica, Medunik USA, Bristol Myer
